publication venue for
- Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma. 2017
- Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. 2009
- Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.. 10. 2012
- Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.. 10. 2012
- Interstitial infusion of erlotinib in the rodent brain.. 8. 2009